| (CHF) | Dec 2020 | Y/Y change |
|---|---|---|
| Revenue | 29.15M | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, BSLN.SW returned +36.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +18.3% |
| 1 year | +36.4% |
| 5 years | +35.4% |
| 10 years | -6.8% |
| All-time high | CHF 282.25 (Mar 2007) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what CHF1,000 in BSLN.SW would be worth today ›No. Basilea Pharmaceutica AG has not paid a dividend in the past 12 months.
Basilea Pharmaceutica AG is part of the Healthcare sector.
Basilea Pharmaceutica AG has a market cap of 800.77M CHF, based on the latest quote.
